Immunology Discovery at AbbVie: Strategies to new therapies for auto-immune and chronic inflammatory diseases
MBC BioLabs San Francisco
953 Indiana Street San Francisco, CA 94107
Dr. Lisa Olson is responsible for the oversight and strategic development of AbbVie's Immunology research program, and is Site Head for the AbbVie Bioresearch Center in Worcester, MA.
Following a post-doctoral fellowship at the University of Chicago, Chicago, IL, Dr. Olson joined the faculty of the OB/GYN Department, Washington University Medical School, St. Louis, MO. In 1998, Olson left Washington University to lead the Women’s Health Program within the Nutrition Sector of Monsanto Corp., St. Louis, MO. Two years later, she joined the Arthritis and Inflammation Department at Pharmacia Corp, St. Louis, MO which subsequently evolved into the Inflammation Department of Pfizer Corp, St. Louis, MO. Dr. Olson joined AbbVie (formerly Abbott) in 2005 as Director, Pharmacology and has had roles of increasing responsibility ever since. In 2008, she was promoted to Senior Director, Pharmacology and Discovery Safety, Metabolism and Pharmokinetics and in 2010 became Divisional Vice President, Immunology Research. Dr. Olson became Site Head of the AbbVie Bioresearch Center in 2012 and the Cambridge Research Center in 2018.
Dr. Olson received her Ph.D. degree at the University of Illinois, Urbana, IL in 1986. She currently serves on the Board of Directors for the Massachusetts Biotechnology Council and is a Trustee for the Massachusetts Biomedical Initiatives.